Status:
COMPLETED
NvisionVLE™ Registry System Registry
Lead Sponsor:
NinePoint Medical
Conditions:
Esophagogastroduodenoscopy
Eligibility:
All Genders
Brief Summary
Prospective, multi-site registry with longitudinal follow up for patients undergoing EGD or endoscopy. The primary objective is to provide a collection of patient NvisionVLE™ procedural data for parti...
Detailed Description
This is a prospective, multi-site registry with longitudinal follow up for patients undergoing EGD or endoscopy. The primary objective is to provide a collection of patient NvisionVLE™ procedural data...
Eligibility Criteria
Inclusion
- Patients presenting for an endoscopic examination of the esophagus
- Ability to provide written, informed consent to participate in the Registry
Exclusion
- Patients for whom use of the NvisionVLE device would be in conflict with the Instructions for Use (IFU)
Key Trial Info
Start Date :
July 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2018
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT02215291
Start Date
July 1 2014
End Date
January 1 2018
Last Update
March 29 2018
Active Locations (18)
Enter a location and click search to find clinical trials sorted by distance.
1
Univeristy of South Alabama
Mobile, Alabama, United States, 36688
2
University of Southern California
Los Angeles, California, United States, 90033
3
University of California Irvine
Orange, California, United States, 92868
4
Mayo Clinic
Jacksonville, Florida, United States, 32224